MiR-0766 induces p53 accumulation and G2/M arrest by directly targeting MDM4

被引:33
|
作者
Wang, Qingqing [1 ]
Selth, Luke A. [2 ,3 ]
Callen, David F. [1 ]
机构
[1] Univ Adelaide, Sch Med, Ctr Personalised Canc Med, Breast Canc Genet Grp, Adelaide, SA, Australia
[2] Univ Adelaide, Sch Med, Dame Roma Mitchell Canc Res Labs, Adelaide, SA, Australia
[3] Univ Adelaide, Discipline Med, Freemasons Fdn Ctr Mens Hlth, Adelaide, SA, Australia
基金
英国医学研究理事会; 澳大利亚国家健康与医学研究理事会;
关键词
MicroRNA; MDM4; p53; cancer; cell cycle; TUMOR-SUPPRESSOR P53; MUTANT P53; MICRORNA EXPRESSION; NEGATIVE REGULATION; POSITIVE FEEDBACK; GENE-EXPRESSION; MIR-34A; PROLIFERATION; ONCOPROTEIN; TRANSITION;
D O I
10.18632/oncotarget.15530
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
p53, a transcription factor that participates in multiple cellular functions, is considered the most important tumor suppressor. Previous evidence suggests that post-transcriptional deregulation of p53 by microRNAs contributes to tumorigenesis, tumor progression and therapeutic resistance. In the present study, we found that the microRNA miR-766 was aberrantly expressed in breast cancer, and that overexpression of miR-766 caused accumulation of wild-type p53 protein in multiple cancer cell lines. Supporting its role in the p53 signalling pathway, miR-766 decreased cell proliferation and colony formation in several cancer cell lines, and cell cycle analyses revealed that miR-766 causes G2 arrest. At a mechanistic level, we demonstrate that miR-766 enhances p53 signalling by directly targeting MDM4, an oncogene and negative regulator of p53. Analysis of clinical genomic data from multiple cancer types supports the relevance of miR-766 in p53 signalling. Collectively, our study demonstrates that miR-766 can function as a novel tumor suppressor by enhancing p53 signalling.
引用
收藏
页码:29914 / 29924
页数:11
相关论文
共 50 条
  • [31] The p53 Negative Regulator, MDM4 but Not MDM2, Is Frequently Activated in Hepatocellular Carcinoma
    Zhou, X.
    Bloomston, M.
    Shirley, L. A.
    Lozanski, A.
    Lozanski, G.
    Frankel, W. L.
    LABORATORY INVESTIGATION, 2013, 93 : 413A - 413A
  • [32] The p53 Negative Regulator, MDM4 but Not MDM2, Is Frequently Activated in Hepatocellular Carcinoma
    Zhou, X.
    Bloomston, M.
    Shirley, L. A.
    Lozanski, A.
    Lozanski, G.
    Frankel, W. L.
    MODERN PATHOLOGY, 2013, 26 : 413A - 413A
  • [33] Protoporphyrin IX is a dual inhibitor of p53/MDM2 and p53/MDM4 interactions and induces apoptosis in B-cell chronic lymphocytic leukemia cells
    Jiang, Liren
    Malik, Natasha
    Acedo, Pilar
    Zawacka-Pankau, Joanna
    CELL DEATH DISCOVERY, 2019, 5 (1)
  • [34] Protoporphyrin IX is a dual inhibitor of p53/MDM2 and p53/MDM4 interactions and induces apoptosis in B-cell chronic lymphocytic leukemia cells
    Liren Jiang
    Natasha Malik
    Pilar Acedo
    Joanna Zawacka-Pankau
    Cell Death Discovery, 5
  • [35] p53 Configures the G2/M arrest response of nucleostemin-deficient cells
    G Huang
    L Meng
    RYL Tsai
    Cell Death Discovery, 1
  • [36] p53 Configures the G2/M arrest response of nucleostemin-deficient cells
    Huang, G.
    Meng, L.
    Tsai, R. Y. L.
    CELL DEATH DISCOVERY, 2015, 1
  • [37] BAI, a novel CDK inhibitor induces apoptosis or G2/M arrest according to p53 state of cancer cell
    Park, J. W.
    Kim, S.
    FEBS JOURNAL, 2013, 280 : 315 - 315
  • [38] Restoration of miR-193a-5p and miR-146 a-5p Expression Induces G1 Arrest in Colorectal Cancer through Targeting of MDM2/p53
    Noorolyai, Saeed
    Baghbani, Elham
    Maleki, Leili Aghebati
    Kojabad, Amir Baghbanzadeh
    Shanehbandi, Dariush
    Shahgoli, Vahid Khaze
    Mokhtarzadeh, Ahad
    Baradaran, Behzad
    ADVANCED PHARMACEUTICAL BULLETIN, 2020, 10 (01) : 130 - 134
  • [39] C-terminus of p53 is required for G2 arrest
    Nakamura, S
    Gomyo, Y
    Roth, JA
    Mukhopadhyay, T
    ONCOGENE, 2002, 21 (13) : 2102 - 2107
  • [40] TARGETING TRISOMY MDM4 INDUCES CELL DEATH IN 1Q+PFA EPENDYMOMA THROUGH REACTIVATION OF THE P53 PATHWAY
    Calzadilla, Annaliese J.
    Griesinger, Andrea M.
    Donson, Andrew M.
    Grimaldo, Enrique
    Madhavan, Krishna
    Alimova, Irina
    Pierce, Angela M.
    Brunt, Breauna
    Vibhakar, Rajeev
    Foreman, Nicholas K.
    NEURO-ONCOLOGY, 2024, 26